SEC
RVMD icon

Seven Eight Capital’s Revolution Medicines RVMD Stock Holding History

Seven Eight Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,309
Closed -$331K – 516
2024
Q3 		$331K Sell
7,309
-62,293
-89% -$2.71M 0.03% 630
2024
Q2 		$2.7M Buy
69,602
+1,108
+2% +$41.4K 0.28% 85
2024
Q1 		$2.21M Buy
+68,494
New +$2.03M 0.23% 129
2023
Q4 		– Sell
-44,247
Closed -$1.22M – 805
2023
Q3 		$1.22M Buy
44,247
+34,944
+376% +$1.04M 0.14% 195
2023
Q2 		$249K Sell
9,303
-1,336
-13% -$32.8K 0.04% 427
2023
Q1 		$230K Buy
+10,639
New +$262K 0.05% 380

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Seven Eight Capital's RVMD Position: Q4 2024 in Review

Seven Eight Capital sold out of Revolution Medicines (RVMD) in Q4 2024, closing a stake of 7,309 shares — an estimated $331K sold.

Seven Eight Capital first reported a position in RVMD in Q1 2023 and held it in 6 quarters. The position peaked at $2.7M in Q2 2024. 281 funds tracked by Wall St. Rank hold RVMD as of Q4 2024.

  • Seven Eight Capital reported no remaining Revolution Medicines position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 7,309 Revolution Medicines shares in Q4 2024, an estimated $331K.
  • Seven Eight Capital first reported a position in Revolution Medicines in Q1 2023 and held it in 6 quarters.
  • Seven Eight Capital's Revolution Medicines position peaked at $2.7M in Q2 2024.
  • 281 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.